189 related articles for article (PubMed ID: 9818754)
21. Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Drugs; 1995; 49 Suppl 2():235-7. PubMed ID: 8549315
[No Abstract] [Full Text] [Related]
22. In-vitro activities of 16 non-beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1999 Apr; 43(4):563-7. PubMed ID: 10350388
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal resistance in the UK.
Goldsmith CE; Moore JE; Murphy PG
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():11-8. PubMed ID: 9484868
[TBL] [Abstract][Full Text] [Related]
24. Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity.
Dalhoff A; Krasemann C; Wegener S; Tillotson G
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S22-9. PubMed ID: 11249825
[TBL] [Abstract][Full Text] [Related]
25. Activity of trovafloxacin against blood isolates of Streptococcus pneumoniae in Sweden.
Liljequist BO; Hoffman BM; Hedlund J
Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):671-5. PubMed ID: 8894578
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe).
Odland BA; Jones RN; Verhoef J; Fluit A; Beach ML
Diagn Microbiol Infect Dis; 1999 Aug; 34(4):315-20. PubMed ID: 10459483
[TBL] [Abstract][Full Text] [Related]
27. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
28. Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci.
Fasola E; Spangler SK; Ednie LM; Jacobs MR; Bajaksouzian S; Appelbaum PC
Antimicrob Agents Chemother; 1996 Nov; 40(11):2661-3. PubMed ID: 8913486
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility of six fluoroquinolones against invasive Streptococcus pneumoniae isolated from 1996 to 2001 in Taiwan.
Chen JY; Fung CP; Wang CC; Chu ML; Siu LK
Microb Drug Resist; 2003; 9(2):211-7. PubMed ID: 12820807
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility of 90 penicillin-susceptible and -resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem.
Hupková H; Trupl J
Folia Microbiol (Praha); 1998; 43(1):68-70. PubMed ID: 9569631
[TBL] [Abstract][Full Text] [Related]
31. Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Plouffe JF
Diagn Microbiol Infect Dis; 1996 May; 25(1):43-5. PubMed ID: 8831044
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates.
Barrett MS; Jones RN
Diagn Microbiol Infect Dis; 1996 Feb; 24(2):113-6. PubMed ID: 9147907
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.
Tomizawa H; Tateda K; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 1998 Jan; 41(1):103-6. PubMed ID: 9511043
[TBL] [Abstract][Full Text] [Related]
34. In vitro antimicrobial activity of levofloxacin against Streptococcus pneumoniae.
Hu BS; Fung CP; Liu PY; Lau YJ; Shi ZY; Lin YH
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Oct; 60(4):191-4. PubMed ID: 9439047
[TBL] [Abstract][Full Text] [Related]
35. [Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico].
Calva-Mercado JJ; Castillo G; López-Vidal Y
Gac Med Mex; 2005; 141(4):253-8. PubMed ID: 16164118
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa isolated in major hospitals in Nagano prefecture].
Hachiya T; Kubo K; Yanagisawa H
Jpn J Antibiot; 2004 Apr; 57(2):157-71. PubMed ID: 15219055
[TBL] [Abstract][Full Text] [Related]
37. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 1996 Oct; 40(10):2431-3. PubMed ID: 8891160
[TBL] [Abstract][Full Text] [Related]
38. E test for studying in vitro activity of seven antimicrobial agents against penicillin-susceptible and penicillin-resistant pneumococci.
Li J; Zhang Y; Chen Y; Hao F; Chen Y
Chin Med J (Engl); 2000 Jul; 113(7):628-31. PubMed ID: 11776034
[TBL] [Abstract][Full Text] [Related]
39. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
Lafredo SC; Foleno BD; Fu KP
Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
